CeloNova BioSciences, Inc., headquartered in San Antonio, Texas, is a global medical device company that develops, manufactures and markets a family of products based upon its novel Polyzene F technology for patients with cardiovascular disease.

Our products are developed and manufactured in Carlsbad, California, U.S.A. and commercially available in markets outside of the United States. The Company’s regional offices are located in France and The Netherlands.